Resverlogix Corp. (“Resverlogix”) (TSX:RVX), announced today that Dr. George Adams, has joined the Scientific Advisory Board. Dr. Adams will help provide strategic consultation for the company’s development in its emerging cardiovascular program for drug eluting technologies, ReVas™.
